Devyser Diagnostics AB (publ) DVYSR

Updated: 11 Jun 2026

Stockholm | Biotech | Genetic diagnostics

No signal published yet

We already track Devyser Diagnostics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Devyser Diagnostics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
Stockholm
Type
Biotech
Sector
Genetic diagnostics
We're already tracking Devyser Diagnostics AB (publ) — here are the latest events we've registered

Recent News

  • On May 22, 2026, Devyser announced the appointment of Niklas Axelsson as the new CFO, with Sabina Berlin transitioning to a role in Investor Relations. In April 2026, the company reported its fourth consecutive quarter of positive operating profit (EBIT) and completed the acquisition of CyberGene AB.

What Firelda Watch includes for Devyser Diagnostics AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Devyser Diagnostics AB (publ) will be delivered in the same format.

Want to follow Devyser Diagnostics AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Devyser Diagnostics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Devyser Diagnostics AB (publ) DVYSR
Devyser Diagnostics — follow and we'll monitor it
Follow Devyser Diagnostics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.